Gastric bypass surgery in NASH: A major modulator of hepatic

Gut

Volumn 64, Issue 4, 2015, Pages 524-526

  Baraille, Floriane ^a,b   Guilmeau, Sandra ^a,b   Postic, Catherine ^a,b  

^a INSTITUT COCHIN   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENOSINE TRIPHOSPHATE; FAT DROPLET; FATTY ACID; FATTY ACID SYNTHASE; GLUCAGON LIKE PEPTIDE 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SATURATED FATTY ACID; SUCROSE; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

CLINICAL FEATURE; DIET; DISEASE MODEL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOPLASMIC RETICULUM STRESS; GLUCOSE TOLERANCE; HEPATIC MITOCHONDRIAL DYSFUNCTION; HEPATITIS; HIGH FAT HIGH SUCROSE DIET; HUMAN; INSULIN RESISTANCE; LIPID STORAGE; LIVER FIBROSIS; NONALCOHOLIC FATTY LIVER; NONHUMAN; NOTE; OBESITY; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ROUX EN Y GASTRIC BYPASS; ROUX Y ANASTOMOSIS; STOMACH BYPASS; WEIGHT REDUCTION; ANIMAL;

ANIMALS; HUMANS;

EID: 84924354883     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2014-307738     Document Type: Note

References (10)

1. Bieghs V, Van Gorp PJ, Wouters K, et al. LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of infl ammation in non-alcoholic fatty liver disease. PLoS One 2012;7:e30668.
2. Ishimoto T, Lanaspa MA, Rivard CJ, et al. High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. Hepatology 2013;58:1632-43.
3. Troy S, Soty M, Ribeiro L, et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab 2008;8:201-11.
4. Verbeek J, Lannoo M, Pirinen E, et al. Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis. Gut 2015;64:673-83.
5. Campbell JE, Drucker DJ. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab 2013;17:819-37.
6. Hao Z, Zhao Z, Berthoud HR, et al. Development and verification of a mouse model for Roux-en-Y gastric bypass surgery with a small gastric pouch. PLoS One 2013;8:e52922.
7. Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 2008;118:829-38.
8. Lassailly G, Caïazzo R, Pattou F, et al. Bariatric surgery for curing NASH in the morbidly obese? J Hepatol 2013;58:1249-51.
9. Mallat A, Lotersztajn S. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis. Am J Physiol Cell Physiol 2013;305:C789-99.
10. Burcelin R, Serino M, Chabo C, et al . Metagenome and metabolism: the tissue microbiota hypothesis. Diabetes Obes Metab 2013;15(Suppl 3):61-70.